"With 300+ board certified pediatric specialists, Rocky Mountain Hospital for Children (RMHC) at Presbyterian/St. Luke’s Medical Center in Denver is a dedicated pediatric hospital and the anchor facility for HealthONE’s system of pediatric care. It is home to The Heart Center at RMHC, The Center for Maternal Fetal Health (for high risk moms and babies) and the largest Level IV Neonatal Intensive Care Unit in the Rocky Mountain region. In addition, RMHC has a center for minimally invasive surgery for infants/children, a Bone Marrow Transplant program, Liver Transplant program, pediatric sarcoma program and hematology/oncology program. RMHC has 6 affiliated Denver-area locations and 2 dedicated pediatric ERs."

During the past decade, Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 46 clinical trials were completed, i.e. on average, 80.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 21 clinical trials were completed. i.e. 105% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "Children's Oncology Group" with 6 trials as a collaborator, "SpringWorks Therapeutics, Inc." with 1 trials as a collaborator and "United Therapeutics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center" are "Recurrent Neuroblastoma" (19 trials), "Recurrent Osteosarcoma" (17 trials), "Refractory Neuroblastoma" (15 trials), "Refractory Non-Hodgkin Lymphoma" (14 trials) and "Recurrent Hepatoblastoma" (13 trials). Many other conditions were trialed in "Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center" are "Drug" (87 trials), "Other" (70 trials), "Procedure" (43 trials), "Biological" (41 trials) and "Radiation" (30 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Cyclophosphamide" (35 trials), "Vincristine Sulfate" (30 trials), "Doxorubicin Hydrochloride" (25 trials) and "Etoposide" (23 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center" are 108 trials for "All" genders.

Currently, there are NaN active trials in "Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center". undefined are not yet recruiting, 30 are recruiting, 48 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, 1 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".